Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study.

Objective: The authors sought to evaluate psychiatric comorbidity, subjective quality of life, and impact of psychopathology on quality of life measures in a clinical sample of patients attending a center for the diagnosis and treatment of obesity compared to a matched sample of non-obese subjects.

Methods: Two hundred ninety-three consecutive obese patients (48 males, 245 females, mean age 45.41 +/- 13.

Obesity and psychopathology. A study of psychiatric comorbidity among patients attending a specialist obesity unit.

Aims: The study aims to evaluate the frequency of association between Axis I and II disorders according to DSMIVTR criteria and obesity, and use of mental health services in a clinical sample of patients attending a centre for the diagnosis and treatment of Obesity.

Methods: 150 consecutive patients (32 Males, 118 females, mean age 44.6 +/- 14.

Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy.

Background: Mood and anxiety symptoms in chronic hepatitis C (CHC) may be related to the patient awareness of the diagnosis and prognosis, to side effects induced by interferon (IFN)-alpha treatment, as well as to substance abuse. However, the observation of metabolic alterations in patients with CHC has led to hypothesize a direct effect of hepatitis C virus (HCV) on brain function. This study was aimed at elucidating whether CHC is associated with specific anxiety or mood disorders independently of confounding factors.